Onco-Innovations Limited (NEO:ONCO)
Canada · Delayed Price · Currency is CAD 0.5700
-0.0200 (-3.39%)
Aug 19, 2026, 3:55 PM EST
Onco-Innovations Market Cap
Onco-Innovations has a market cap or net worth of CAD 38.94 million as of August 19, 2026. Its market cap has decreased by -62.24% in one year.
Market Cap
38.94M
Enterprise Value
38.16M
Revenue
110.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
ChartMarket Cap Chart
Since November 27, 2024, Onco-Innovations's market cap has increased from 28.39M to 38.94M, an increase of 37.16%. That is a compound annual growth rate of 20.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 38.94M | -48.66% |
| Dec 30, 2025 | 75.84M | 115.86% |
| Dec 31, 2024 | 35.13M | 23.76% |
| Nov 27, 2024 | 28.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sona Nanotech | 44.82M |
| BriaCell Therapeutics | 42.19M |
| Microbix Biosystems | 39.72M |
| Sernova Biotherapeutics | 39.65M |
| MedMira | 38.60M |
| Thiogenesis Therapeutics | 38.49M |
| Medicenna Therapeutics | 38.30M |
| Defence Therapeutics | 37.89M |